Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma

Cancer Science

Volumn 96, Issue 9, 2005, Pages 535-542

  Kono, Suminori ^a   Chen, Kun ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYANOCOBALAMIN; FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PYRIDOXINE;

ALCOHOL CONSUMPTION; ALLELE; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; DIETARY INTAKE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; NUTRITIONAL STATUS; PREVALENCE; PRIORITY JOURNAL; PROTECTION; REVIEW;

ADENOMA; COLORECTAL NEOPLASMS; EPIDEMIOLOGIC STUDIES; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NUTRITIONAL STATUS; POLYMORPHISM, GENETIC;

EID: 27144526086     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00090.x     Document Type: Review

References (47)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 2001; 94: 153-6.
2. Stewart BW, Kleihues P, eds. World Cancer Report. Lyon: IARC Press, 2003; 198-202.
3. Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev 2004; 13: 127-32.
4. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-70.
5. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
6. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002; 132: 2350S-2355S.
7. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004; 159: 423-43.
8. Lucock M. Folic acid: nutritional biochemistry, molecular biology and role in disease processes. Mol Genet Metab 2000; 71: 121-38.
9. Lucock M. Is folic acid the ultimate functional food component for disease prevention? BMJ 2004; 328: 211-4.
10. Warnecke PM, Bestor TH. Cytosine methylation and human cancer. Curr Opin Oncol 2000; 12: 68-73.
11. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 1988; 48: 1159-61.
12. Ballestar E, Esteller M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 2002; 23: 1103-9.
13. Blount BC, Mack MM, Wehr CM et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94: 3290-5.
14. Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 1999; 55: 578-92.
15. Duthie SJ, Narayanan S, Blum S, Piric L, Brand G. Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excision repair in immortalized normal colon epithelial cells. Nutr Cancer 2000; 37: 245-51.
16. Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
17. van der Put NM, Gabreels F, Stevens EM et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-51.
18. Chen J, Giovannucci E, Kelsey K et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56: 4862-4.
19. Ma J, Stampfer MJ, Giovannucci E et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098-102.
20. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 513-8.
21. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 2002; 13: 239-48.
22. Keku T, Millikan R, Worley K et al. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 2002; 11: 1611-20.
23. Delgado-Enciso I, Martinez-Garza SG, Rojas-Martinez A et al. 677T mutation of the MTHFR gene in adenomas and colorectal cancer in a population sample from the Northeastern Mexico. Preliminary results. Rev Gastroenterol Mex 2001; 66: 32-7.
24. Sachse C, Smith G, Wilkie MJ et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002; 23: 1839-49.
25. Plaschke J, Schwanebeck U, Pistorius S, Saeger HD, Schackert HK. Methylenetetrahydrofolate reductase polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability. Cancer Lett 2003; 191: 179-85.
26. Toffoli G, Gafa R, Russo A et al. Methylenetetrahydrofolate reductase 677 C→T polymorphism and risk of proximal colon cancer in north Italy. Clin Cancer Res 2003; 9: 743-8.
27. Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM. Colorectal cancer and the methylenetetrahydrofolate reductase 677 C→T and methionine synthase 2756 A→G polymorphisms: a study of 2168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004; 13: 2175-80.
28. Shannon B, Gnanasampanthan S, Beilby J, Iacopetta B. A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut 2002; 50: 520-4.
29. Jiang QT, Chen K, Ma XY et al. A case-control study on the polymorphisms of methylenetetrahydrofolate reductases, drinking interaction and susceptibility in colorectal cancer (in Chinese). Zhonghua Liu Xing Bing Xue Za Zhi [Chin J Epidemiol] 2004; 25: 612-6.
30. Park KS, Mok JW, Kim JC. The 677C > T mutation in 5,10-methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test 1999; 3: 233-6.
31. Kim DH, Ahn YO, Lee BH, Tsuji E, Kiyohara C, Kono S. Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. Cancer Lett 2004; 216: 199-205.
32. Matsuo K, Hamajima N, Hirai T et al. Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev 2002; 3: 353-9.
33. Yin G, Kono S, Toyomura K et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal. Cancer Study. Cancer Sci 2004; 95: 908-13.
34. Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ. Linkage disequilibrium between the 677C > T and 1298A > C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 2002; 12: 339-42.
35. Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 285-92.
36. Ministry of Health, Labour and Welfare, Japan. The National Nutrition Survey in Japan, 2001. Tokyo: Dai-ichi Shuppan, 2003. (In Japanese.)
37. Halsted CH, Villanueva JA, Devlin AM, Chandler CJ. Metabolic interactions of alcohol and folate. J Nutr 2002; 132: 2367S-2372S.
38. World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington, DC: American Institute for Cancer Research, 1997.
39. Chen J, Giovannucci E, Hankinson SE et al. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 1998; 19: 2129-32.
40. Ulrich CM, Kampman E, Bigler J et al. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev 1999; 8: 659-68.
41. Levine AJ, Siegmund KD, Ervin CM et al. The methylenetetrahydrofolate reductase 677C > T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2000; 9: 657-63.
42. Giovannucci E, Chen J, Smith-Warner SA et al. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003; 12: 970-9.
43. Marugame T, Tsuji E, Inoue H et al. Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas. Cancer Lett 2000; 151: 181-6.
44. Hirose M, Kono S, Tabata S et al. Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use and risk of colorectal adenomas: Self-Defense Forces Health Study. Cancer Sci 2005; 96: 513-8.
45. Ulvik A, Evensen ET, Lien EA et al. Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet 2001; 101: 246-54.
46. Marugame T, Tsuji E, Kiyohara C et al. Relation of plasma folate and methylenetetrahydrofolate reductase C677T polymorphism to colorectal adenomas. Int J Epidemiol 2003; 32: 64-6.
47. Friso S, Choi SW, Girelli D et al. A common mutation in the 5,10-methlenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002; 99: 5606-11.